salvin has been researched along with Atherogenesis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jain, KS; Kathiravan, MK; Shishoo, CJ; Somani, RS | 1 |
| Chae, IG; Chun, KS; Im, NK; Jung, YT; Lee, IS; Lee, J; Yu, MH | 1 |
| Chang, WC; Lin, HC; Yu, YM | 1 |
1 review(s) available for salvin and Atherogenesis
| Article | Year |
|---|---|
The biology and chemistry of hyperlipidemia.
Topics: Animals; Atherosclerosis; Biochemical Phenomena; Biochemistry; Disease Progression; Drug Design; Humans; Hyperlipidemias; Lipoproteins | 2007 |
2 other study(ies) available for salvin and Atherogenesis
| Article | Year |
|---|---|
Effect of Rosemarinus officinalis L. on MMP-9, MCP-1 levels, and cell migration in RAW 264.7 and smooth muscle cells.
Topics: Abietanes; Animals; Anti-Inflammatory Agents; Atherosclerosis; Blotting, Western; Cell Line; Cell Movement; Chemokine CCL2; Chromatography, High Pressure Liquid; Matrix Metalloproteinase 9; Mice; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Plant Extracts; Rosmarinus; Tumor Necrosis Factor-alpha | 2012 |
Carnosic acid prevents the migration of human aortic smooth muscle cells by inhibiting the activation and expression of matrix metalloproteinase-9.
Topics: Abietanes; Analysis of Variance; Antioxidants; Aorta; Atherosclerosis; Cell Movement; Cells, Cultured; Depression, Chemical; Dose-Response Relationship, Drug; Enzyme Activation; Gene Expression; Humans; Matrix Metalloproteinase 9; Myocytes, Smooth Muscle; NF-kappa B; Plant Extracts; Reactive Oxygen Species; Salvia miltiorrhiza; Tumor Necrosis Factor-alpha | 2008 |